Skip to main content

Search

Search the site:

News, Views, and Advocacy From the Oncology Nursing Society

News & Views

Advocacy

Stories

News & Views

Latest Articles
Clinical Practice
ONS News
ONS Leadership

Trending Topics

Treatments
Research
Safety
COVID-19
ONS Congress
Clinical practice

View All Topics

Advocacy

Latest Articles
Updates
Get Involved

Stories View All

View All

Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers

nursing professional development

Zoom Through Video Job Interviews With These Tips for Applicants and Hiring Managers

January 22, 2021

The Case of Concurrent Therapy Concerns

Treatment side effects

The Case of Concurrent Therapy Concerns

December 18, 2020

In a World Where You Can Be Anything, Be Kind

In a World Where You Can Be Anything, Be Kind

December 11, 2020

Nursing Innovation Links Rural Facilities to Resources and Experts to Provide High-Quality Care Across the Country

Access to cancer care

Nursing Innovation Links Rural Facilities to Resources and Experts to Provide High-Quality Care Across the Country

December 04, 2020

Why All Oncology Nurses Should Be Environmentalists

Oncology nurse influence

Why All Oncology Nurses Should Be Environmentalists

November 27, 2020

Search

News & Views

Advocacy

Stories

Home

Author Content

Genetics & genomics

Genomics Provides Insight on Exceptionally Responding Patients

Patients with cancer who experience unexpected and long-lasting treatment outcomes are considered exceptional responders, but researchers and clinicians had no insight as to why the patients did so well with treatment. Results of a new study now show that genomic characterizations of cancer can uncover genetic alterations that may contribute to the phenomenon, researchers reported in Cancer Cell.

January 13, 2021

Clinical practice guidelines

Manage Cancer Treatment-Related Radiodermatitis With ONS Guidelines™

Painful skin reactions may develop in as many as 95% of patients receiving radiotherapy treatments for cancer. Patients report that it affects their quality of life and that purchasing interventions to soothe their skin increases their out-of-pocket costs. Supporting patients who experience the side effect is critical for their well-being.

January 12, 2021

Cancer research

How COVID-19 May Increase Access to and Reduce Disparities in Cancer Clinical Trials

To improve clinical trial availability, effectiveness, and diversity in the era of the COVID-19 coronavirus, National Cancer Institute (NCI)-funded clinical trials should adjust their design to increase use of telemedicine and remote informed consent, among other strategies, several NCI department leaders wrote in a commentary in the Journal of the National Cancer Institute.

January 06, 2021

Adding Nivolumab to Chemo Improves Survival for Advanced Gastric Cancer

First-line therapy combining nivolumab with chemotherapy improved median overall survival rates in patients with PD-L1-expressing gastric cancer by 3.3 months in a large international, multicenter trial. The findings were reported during the 2020 European Society for Medical Oncology virtual meeting.

December 30, 2020

Genomics May Trick PARP Inhibitors to Treat More Cancers

Turning on the body’s inflammasome with epigenetic therapy may improve the efficacy of PARP inhibitors across multiple tumor types, possibly expanding the therapy’s application to new cancers, researchers reported in Proceedings of the National Academy of Sciences.

December 23, 2020

Clinical practice guidelines

Manage Cancer Treatment-Related Constipation With ONS Guidelines™

As many as 43%–58% of patients with cancer experience constipation related to their treatment, and the side effect is both distressing and potentially life threatening if severe enough. Constipation-related emergency department visits increased by 41.5% from 2006–2011, with older adults (aged 85 years or older) making up most of the visits. Estimates suggest that the cost of managing severe cancer-related constipation may range from $500 to more than $2,300 per person per month. Supporting patients who experience the side effect is critical for their well-being.

December 08, 2020

NKT Cells May Be the Next Wave of CAR Therapy

When genetically modified with a chimeric antigen receptor (CAR), natural killer T (NKT) cells eliminated 50% of metastases in a patient with heavily pretreated, relapsed or refractory metastatic neuroblastoma, according to interim findings from an ongoing study that were published in Nature Medicine.

December 02, 2020

Cancer screening

Older Adults Are Being Overscreened for Cancer

Many older adults are continuing cancer screenings beyond the recommended upper age limits, which range from age 65–75 years depending on the type of cancer screening, researchers reported in JAMA Network Open.

November 25, 2020

Aspirin’s Cancer Benefits May Not Translate to Older Adults

Healthy older adults who take daily low-dose aspirin have increased risk of being diagnosed with advanced cancers and dying from cancer, according to findings from a new study published in the Journal of the National Cancer Institute.

November 18, 2020

Patients With Gynecologic Cancers Have Significant Fatigue After Surgery

Forty-eight percent of women with gynecologic cancers report experiencing clinically significant fatigue after surgery that may continue six months (44%) and one (39%) year later, researchers reported in study findings published in Cancer.

November 12, 2020

Clinical practice

Manage Cancer Treatment-Related Skin Toxicities With ONS Guidelines™

From chemotherapy to immunotherapy, many of today’s cancer treatments are associated with skin toxicities. Left unmanaged, they can affect patients’ activities of daily living, self-image, and overall quality of life and may lead to treatment disruptions, delays, or even discontinuation.

November 10, 2020

Cervical cancer

ACS Cervical Cancer Screening Guidelines Prefer HPV Over Pap Tests

People with a cervix who are aged 25–65 years should receive a human papillomavirus (HPV) test every five years, according to the new American Cancer Society (ACS) guidelines for cervical cancer screening.

November 04, 2020

Study Links HPV Vaccine to Reduced Rates of Cervical Cancer

Cervical cancer rates have dropped more than 90% among women who received the human papillomavirus (HPV) vaccine, according to the results of a Swedish study published in the New England Journal of Medicine. Global health leaders are calling it a milestone study.

October 23, 2020

Treatment side effects

Manage Cancer Treatment-Related Lymphedema With ONS Guidelines™

Surgical treatment for breast, gynecologic, prostate, lymphoma, melanoma, or head and neck cancers puts patients at risk for developing secondary lymphedema at any point in the remainder of their life. Studies show that as many as 10%–40% of patients with breast cancer may experience breast cancer–related lymphedema.

October 13, 2020

Cancer research

Blocking Fatty Acid Storage May Induce Glioblastoma Apoptosis

Turning off an enzyme that glioblastoma cells use to store the fatty acids they feed on as energy for rapid cell division may offer a new treatment option for the deadly cancer, researchers reported in Cell Metabolism.

September 23, 2020

Cancer healthcare advocacy

Be a Catalyst for Change Like Justice Ginsburg

U.S. Supreme Court Justice Ruth Bader Ginsburg was known for being a fighter—for women’s rights and equality, social justice, and even her own health, battling five bouts of cancer diagnoses. On Friday, September 18, 2020, the 87-year-old passed away from metastatic pancreatic cancer.

September 19, 2020

Cancer research

Medications That Affect Microbiome May Influence Checkpoint Inhibitory Response

Common classes of non-cancer medications that affect a patient’s microbiome are associated with increased or decreased survival with immune checkpoint inhibitor drugs, researchers reported in study findings published in BMC Cancer.

September 16, 2020

Treatment side effects

ONS Guidelines™ Offer Framework for Managing Treatment-Related Hot Flashes

Because of treatment effects on hormones, women with breast cancer and men with prostate cancer have an increased risk of frequent and severe hot flashes after treatment. As many as 80% of patients across both genders experience the symptom, which can have an impact on sleep, mood, energy, and sexual function.

September 10, 2020

Cancer research

MicroRNA May Be Key Factor in High-Grade Ovarian Cancer Development

The miR-181a microRNA may turn off two genes and lead to the development of high-grade serous ovarian cancer, researchers reported in Nature Communications. The finding is significant because not much is known about how ovarian cancer develops and it’s difficult to detect in its earlier stages.

September 09, 2020

Cancer research

Treating Mental Health May Improve Lung Cancer Survival

Patients with lung cancer who also had mental health disorders saw improved cancer-related outcomes when their mental illness was treated, according to findings from a study published in JAMA Oncology.

September 02, 2020

Nurse self-care

PTSD Is More Common Among Nurses Than You May Realize

Almost 96% of nurses report experiencing at least one symptom of post-traumatic stress disorder (PTSD) and nearly 21% meet the criteria for a clinical diagnosis of PTSD, according to findings from a literature review published in the Journal of Clinical Nursing.

August 26, 2020

ACA Led to Higher Rates of Early Breast Cancer Diagnoses

Thanks to expanded Medicaid coverage from the Affordable Care Act (ACA), women diagnosed with breast cancer—and in particular, African American women who are more likely to experience breast cancer disparities—are getting their cancers found at earlier stages, according to researchers. The study findings were reported in JAMA Surgery.

August 19, 2020

Early Use of Immunotherapy Has Better Outcomes for Bladder Cancer

Starting immunotherapy for bladder cancer shortly after initial treatment with chemotherapy is better than taking an extended break from cancer treatment, according to results from a study reported at the American Society of Clinical Oncology annual meeting.

August 12, 2020

Manage Immune-Related Adverse Events in Patients on Durvalumab

Durvalumab immunotherapy became a new standard of care for patients with stage III unresectable non-small cell lung cancer whose disease did not progress following two cycles of platinum-based chemoradiotherapy after its approval in February 2018, and in March 2020, its indication was expanded for use as first-line treatment in patients with extensive-stage small cell lung cancer as well. Key to keeping patients on immunotherapy treatment and giving them the best chance at long-term survival is effective management of immune-related adverse events.

August 11, 2020

Cancer research

A Single Blood Test Could One Day Identify 10 Types of Cancer

When combined with positron-emission and computed tomography, a multicancer blood test identified 10 different tumor types in a sample of women with no history of cancer, researchers reported in Science.

August 05, 2020

Current page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

To discuss the information in this article with other oncology nurses, visit the ONS Communities.

To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

content['#byline_profile'].image_alt_text

Elisa Becze BA, ELS, Editor

News, Views, and Advocacy From the Oncology Nursing Society

Legal Notices

Contact Us

Conferences

Advertising

Newsroom

Sitemap

Oncology Nursing Foundation

© Copyright 2021 Oncology Nursing Society

Back to Top ▲